HIG Stock Cash Flow Statements

The Hartford Financial Services Group Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

The Hartford Financial Services Group Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-09-30	2005-06-30	2005-03-31	2004-09-30

operating activities
net income	995,000,000	630,000,000	853,000,000	767,000,000	738,000,000	753,000,000	771,000,000	651,000,000	547,000,000	535,000,000	589,000,000	339,000,000	442,000,000	445,000,000	729,000,000	482,000,000	905,000,000	249,000,000	537,000,000	273,000,000	127,000,000	0	24,000,000	511,000,000	619,000,000	666,000,000	76,000,000	319,000,000	557,000,000	-220,000,000	-15,000,000	-1,209,000,000	-806,000,000	-2,631,000,000	543,000,000	145,000,000	595,000,000	851,000,000	627,000,000	876,000,000	783,000,000	758,000,000	476,000,000	728,000,000	539,000,000	602,000,000	666,000,000	494,000,000
adjustments to reconcile net income to net cash from operating activities:
net realized losses	10,000,000	49,000,000	17,000,000	13,000,000	59,000,000	-28,000,000	27,000,000	90,000,000	64,000,000	7,000,000	-22,000,000	166,000,000	338,000,000	145,000,000
amortization of deferred policy acquisition costs	625,000,000	607,000,000	591,000,000	585,000,000	561,000,000	545,000,000	534,000,000	517,000,000	502,000,000	491,000,000	475,000,000	467,000,000	453,000,000	440,000,000	428,000,000	419,000,000	417,000,000	416,000,000	419,000,000	437,000,000
additions to deferred policy acquisition costs	-700,000,000	-655,000,000	-560,000,000	-610,000,000	-637,000,000	-601,000,000	-523,000,000	-545,000,000	-543,000,000	-548,000,000	-470,000,000	-499,000,000	-483,000,000	-495,000,000	-421,000,000	-445,000,000	-436,000,000	-449,000,000	-398,000,000	-447,000,000
depreciation and amortization	94,000,000	92,000,000	84,000,000	85,000,000	60,000,000	127,000,000	124,000,000	128,000,000	129,000,000	129,000,000	140,000,000	153,000,000	164,000,000	168,000,000	165,000,000	168,000,000	173,000,000	174,000,000	151,000,000	134,000,000	136,000,000	148,000,000	256,000,000	128,000,000	147,000,000	134,000,000	171,000,000	144,000,000	110,000,000	101,000,000	122,000,000	137,000,000	98,000,000	-213,000,000	286,000,000	190,000,000	310,000,000	202,000,000	170,000,000	112,000,000	219,000,000	69,000,000	274,000,000	44,000,000	156,000,000	183,000,000	29,000,000	-8,000,000
other operating activities	54,000,000	115,000,000	92,000,000	39,000,000	79,000,000	119,000,000	47,000,000	19,000,000	25,000,000	122,000,000	66,000,000			15,000,000	45,000,000	-90,000,000	-103,000,000	15,000,000	-44,000,000	79,000,000	-388,000,000	154,000,000	53,000,000	-352,000,000	-138,000,000	68,000,000	6,000,000	-150,000,000	177,000,000
change in assets and liabilities:
decrease in reinsurance recoverables					26,000,000	11,000,000
net change in accrued and deferred income taxes	-285,000,000	104,000,000	79,000,000	-24,000,000	-257,000,000	102,000,000	44,000,000	176,000,000	-339,000,000	90,000,000	104,000,000	-57,000,000	-168,000,000	41,000,000	199,000,000	-90,000,000	-94,000,000	70,000,000	22,000,000	53,000,000
increase in insurance liabilities	669,000,000	1,115,000,000	530,000,000	621,000,000	1,037,000,000	870,000,000	541,000,000	547,000,000	-30,000,000	761,000,000	540,000,000	651,000,000	559,000,000	449,000,000	312,000,000	774,000,000	334,000,000	996,000,000	407,000,000	235,000,000
net change in premiums receivable and agents' balances	-338,000,000	-414,000,000	136,000,000	167,000,000	-365,000,000	-396,000,000	-78,000,000	30,000,000	-326,000,000	-334,000,000
net change in other assets and other liabilities	85,000,000	-608,000,000	142,000,000	36,000,000	-41,000,000	-405,000,000	285,000,000	210,000,000	-91,000,000	-411,000,000	565,000,000	185,000,000	-225,000,000	-674,000,000	284,000,000	181,000,000	-57,000,000	-566,000,000	578,000,000	-622,000,000
net cash from operating activities	1,291,000,000	985,000,000	1,874,000,000	1,678,000,000	1,260,000,000	1,097,000,000	1,627,000,000	1,771,000,000	-49,000,000	871,000,000	1,084,000,000	1,521,000,000	974,000,000	429,000,000	1,204,000,000	1,292,000,000	838,000,000	759,000,000	1,216,000,000	298,000,000	650,000,000	660,000,000	490,000,000	474,000,000	1,064,000,000	1,045,000,000	712,000,000	488,000,000	229,000,000	759,000,000	976,000,000	1,010,000,000	1,254,000,000	677,000,000	1,694,000,000	567,000,000	1,424,000,000	1,620,000,000	1,642,000,000	1,305,000,000	1,852,000,000	1,262,000,000	1,156,000,000	1,368,000,000	1,518,000,000	763,000,000	666,000,000	974,000,000
capex	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-9,000,000	-49,000,000	-87,000,000	-10,000,000	-118,000,000	-67,000,000	-24,000,000	-161,000,000	-29,000,000	-61,000,000	-79,000,000	-51,000,000	-44,000,000	-21,000,000	-53,000,000	-101,000,000	-15,000,000	-49,000,000
free cash flows	1,291,000,000	985,000,000	1,874,000,000	1,678,000,000	1,260,000,000	1,097,000,000	1,627,000,000	1,771,000,000	-49,000,000	871,000,000	1,084,000,000	1,521,000,000	974,000,000	429,000,000	1,204,000,000	1,292,000,000	838,000,000	759,000,000	1,216,000,000	298,000,000	650,000,000	660,000,000	490,000,000	474,000,000	1,064,000,000	1,045,000,000	712,000,000	488,000,000	229,000,000	759,000,000	967,000,000	961,000,000	1,167,000,000	667,000,000	1,576,000,000	500,000,000	1,400,000,000	1,459,000,000	1,613,000,000	1,244,000,000	1,773,000,000	1,211,000,000	1,112,000,000	1,347,000,000	1,465,000,000	662,000,000	651,000,000	925,000,000
investing activities
proceeds from the sale/maturity/prepayment of:
fixed maturities, afs	2,629,000,000	2,126,000,000	2,823,000,000	2,834,000,000	3,603,000,000	1,548,000,000	1,898,000,000	1,401,000,000	1,279,000,000	2,228,000,000
fixed maturities, at fair value using the fair value option	84,000,000	25,000,000		0
equity securities, at fair value	90,000,000	35,000,000		4,000,000	128,000,000	176,000,000		37,000,000	434,000,000	1,422,000,000		85,000,000	93,000,000	257,000,000		200,000,000	160,000,000	157,000,000		645,000,000
mortgage loans	496,000,000	237,000,000	296,000,000	33,000,000	246,000,000	165,000,000	178,000,000	296,000,000	358,000,000	204,000,000	109,000,000	164,000,000	262,000,000	438,000,000	414,000,000	234,000,000	551,000,000	307,000,000	238,000,000	329,000,000	149,000,000	138,000,000	158,000,000	70,000,000	206,000,000	220,000,000	571,000,000	726,000,000	149,000,000	183,000,000	270,000,000	27,000,000	35,000,000	137,000,000	96,000,000	118,000,000	120,000,000	332,000,000	749,000,000	164,000,000	143,000,000	63,000,000	68,000,000	118,000,000
limited partnership and other alternative investments	59,000,000	56,000,000		35,000,000	69,000,000	32,000,000		83,000,000	51,000,000	96,000,000
payments for the purchase of:
net proceeds from (payments for) derivatives			-13,000,000	46,000,000			4,000,000	-96,000,000
net additions of property and equipment	-40,000,000	-38,000,000		-60,000,000	-61,000,000	-50,000,000		-52,000,000	-50,000,000	-49,000,000		-45,000,000	-46,000,000	-31,000,000		-45,000,000	-24,000,000	-23,000,000		-23,000,000
net proceeds from short-term investments	-207,000,000	731,000,000		-238,000,000				26,000,000												407,000,000
other investing activities	-29,000,000	-24,000,000	19,000,000	-27,000,000			-10,000,000	-2,000,000	-2,000,000	-7,000,000	-11,000,000	-1,000,000	14,000,000	2,000,000	-118,000,000	-49,000,000	4,000,000	-6,000,000	11,000,000	-5,000,000	-38,000,000	-32,000,000	-41,000,000	-46,000,000	-85,000,000	-149,000,000	102,000,000	-58,000,000	-43,000,000
net cash from investing activities	-743,000,000	-401,000,000	-1,356,000,000	-1,089,000,000	-888,000,000	-435,000,000	-1,165,000,000	-1,319,000,000	499,000,000	-446,000,000	-572,000,000	-1,092,000,000	261,000,000	126,000,000	-718,000,000	-1,169,000,000	-129,000,000	-450,000,000	-1,059,000,000	777,000,000	-286,000,000	-89,000,000	-1,061,000,000	254,000,000	-148,000,000	-1,886,000,000	1,501,000,000	99,000,000	698,000,000	-264,000,000	-2,546,000,000	-1,011,000,000	-4,778,000,000	268,000,000	-2,497,000,000	-1,820,000,000	-1,272,000,000	-1,746,000,000	-1,962,000,000	-1,196,000,000	-2,580,000,000	-1,441,000,000	-2,143,000,000	-1,246,000,000	-1,776,000,000	-952,000,000	-947,000,000	-1,633,000,000
financing activities
deposits and other additions to investment and universal life-type contracts	36,000,000	27,000,000	22,000,000	22,000,000	27,000,000	37,000,000	21,000,000	27,000,000	30,000,000	18,000,000	21,000,000	21,000,000	21,000,000	25,000,000	23,000,000	24,000,000	20,000,000	22,000,000	16,000,000	15,000,000	3,112,000,000	2,579,000,000	2,502,000,000	3,338,000,000	3,144,000,000	3,048,000,000	942,000,000	5,468,000,000	3,081,000,000	3,835,000,000	4,451,000,000	2,872,000,000	5,263,000,000	4,407,000,000	5,638,000,000	5,707,000,000	6,179,000,000	9,697,000,000	8,173,000,000	8,445,000,000
withdrawals and other deductions from investment and universal life-type contracts	-31,000,000	-26,000,000	-19,000,000	-23,000,000	-30,000,000	-43,000,000	-22,000,000	-29,000,000	-7,000,000	-42,000,000	-15,000,000	-19,000,000	-35,000,000	-33,000,000	-18,000,000	-20,000,000	7,000,000	-44,000,000	-24,000,000	-10,000,000	-4,899,000,000	-4,422,000,000	-5,527,000,000	-6,174,000,000	-6,050,000,000	-5,243,000,000	-5,569,000,000	-5,614,000,000	-5,813,000,000	-7,012,000,000	-6,801,000,000	-4,715,000,000	-5,517,000,000	-6,582,000,000	-7,195,000,000	-6,499,000,000	-7,765,000,000	-7,577,000,000	-8,054,000,000	-7,047,000,000
net (issuance) return of shares under incentive and stock compensation plans, including related excise tax benefit
treasury stock acquired, including related excise tax paid
dividends paid on preferred stock	-5,000,000	-5,000,000	-5,000,000	-6,000,000	-5,000,000	-5,000,000	-5,000,000	-6,000,000	-5,000,000	-5,000,000	-5,000,000	-6,000,000	-5,000,000	-5,000,000	-5,000,000	-6,000,000	-5,000,000	-5,000,000	-5,000,000	-5,000,000	-10,000,000	-11,000,000	-10,000,000	-11,000,000	-10,000,000	-11,000,000	0	-64,000,000	-42,000,000	-23,000,000	0	-8,000,000
dividends paid on common stock	-149,000,000	-150,000,000	-137,000,000	-138,000,000	-140,000,000	-141,000,000	-129,000,000	-131,000,000	-134,000,000	-134,000,000	-123,000,000	-126,000,000	-127,000,000	-130,000,000	-120,000,000	-123,000,000	-126,000,000	-116,000,000	-116,000,000	-108,000,000	-46,000,000	-43,000,000	-45,000,000	-19,000,000	-23,000,000	-22,000,000	-20,000,000	-20,000,000	-20,000,000	-14,000,000	-16,000,000	-99,000,000
net cash from financing activities	-543,000,000	-608,000,000	-547,000,000	-520,000,000	-480,000,000	-529,000,000	-454,000,000	-489,000,000	-459,000,000	-545,000,000	-457,000,000	-480,000,000	-1,187,000,000	-586,000,000	-618,000,000	-30,000,000	-667,000,000	-266,000,000	-199,000,000	-1,027,000,000	-370,000,000	80,000,000	132,000,000	-451,000,000	-560,000,000	-428,000,000	-1,315,000,000	-652,000,000	-1,169,000,000	-646,000,000	2,212,000,000	126,000,000	3,240,000,000	-968,000,000	652,000,000	1,350,000,000	-176,000,000	193,000,000	210,000,000	272,000,000	808,000,000	490,000,000	633,000,000	-16,000,000	701,000,000	-193,000,000	567,000,000	781,000,000
foreign exchange rate effect on cash	-2,000,000	6,000,000	-18,000,000	2,000,000			0	-4,000,000	13,000,000	-6,000,000	4,000,000	-12,000,000			-1,000,000	-6,000,000	4,000,000	-3,000,000	11,000,000	-9,000,000	-2,000,000	40,000,000	20,000,000	-22,000,000		-22,000,000	21,000,000	2,000,000	-33,000,000	10,000,000	65,000,000	-85,000,000	132,000,000	-98,000,000	-13,000,000	140,000,000	83,000,000	261,000,000	-56,000,000	-15,000,000	-11,000,000	-37,000,000	41,000,000	15,000,000	11,000,000	-30,000,000	5,000,000
net increase in cash and restricted cash	3,000,000	-18,000,000	-47,000,000	71,000,000	-112,000,000	133,000,000					59,000,000	-63,000,000	42,000,000	-31,000,000	-60,000,000	89,000,000	28,000,000	41,000,000	-31,000,000	39,000,000
cash and restricted cash – beginning of period	0	234,000,000		0	0	189,000,000		0	0	344,000,000		0	0	337,000,000		0	0	239,000,000		262,000,000
cash and restricted cash– end of period	3,000,000	216,000,000		71,000,000	-112,000,000	322,000,000		-41,000,000	4,000,000	218,000,000		-63,000,000	42,000,000	306,000,000		89,000,000	28,000,000	280,000,000		301,000,000
supplemental disclosure of cash flow information
income tax paid	520,000,000	4,000,000	149,000,000	206,000,000	455,000,000	2,000,000	140,000,000	12,000,000			94,000,000	175,000,000	278,000,000	1,000,000	57,000,000	206,000,000				1,000,000
interest paid	42,000,000	61,000,000	43,000,000	62,000,000	54,000,000	52,000,000	54,000,000	52,000,000	42,000,000	61,000,000	40,000,000	56,000,000	49,000,000	67,000,000	49,000,000	58,000,000	49,000,000	58,000,000	49,000,000	74,000,000	161,000,000	90,000,000	161,000,000	89,000,000	161,000,000
table of contents
decrease (increase) in reinsurance recoverables		-50,000,000							13,000,000	29,000,000										-75,000,000
net proceeds from derivatives		12,000,000								23,000,000				26,000,000				27,000,000		161,000,000
net return of shares under incentive and stock compensation plans		-54,000,000			18,000,000	-27,000,000		0	7,000,000	-32,000,000									6,000,000	-32,000,000
treasury stock acquired		-400,000,000		-400,000,000	-350,000,000	-350,000,000	-350,000,000	-350,000,000	-350,000,000	-350,000,000	-350,000,000	-350,000,000	-450,000,000	-400,000,000	-500,000,000	-511,000,000	-568,000,000	-123,000,000	0	-150,000,000													0	-189,000,000			-21,000,000	-372,000,000	0	-800,000,000
adjustments to reconcile net income to net cash from operating activities
loss on extinguishment of debt											0	0
increase in reinsurance recoverables							-145,000,000				-341,000,000	73,000,000	-100,000,000	-105,000,000	-325,000,000	-37,000,000	-154,000,000	-66,000,000
fixed maturities, fvo							1,000,000	0
equity securities at fair value
limited partnerships and other alternative investments
net additions to property and equipment
net payments for short-term investments										-180,000,000				-207,000,000		-227,000,000
repayment of debt											0	0							0	-500,000,000
net issuance (return) of shares under incentive and stock compensation plans, including related excise tax benefit
cash and restricted cash — beginning of period
cash and restricted cash — end of period
net issuance (return) of shares under incentive and stock compensation plans											15,000,000	0	9,000,000	-43,000,000	2,000,000	18,000,000
net proceeds from (payments for) short-term investments						875,000,000						-237,000,000						-54,000,000
loss on sale of business															1,000,000
proceeds from businesses sold, net of cash transferred
proceeds from the issuance of debt															0
net increase in cash and restricted cash, including cash classified within assets held for sale											59,000,000	-63,000,000	42,000,000	-31,000,000	-133,000,000	87,000,000	46,000,000	40,000,000	-31,000,000
less: net decrease in cash classified as assets held for sale
net decrease in cash and restricted cash										-126,000,000
net (payments for) short-term investments
net decrease in securities loaned or sold under agreements to repurchase																			-76,000,000
less: net increase in cash classified as assets held for sale
fixed maturities, available-for-sale												2,371,000,000	3,469,000,000	6,578,000,000	6,316,000,000	4,771,000,000	5,834,000,000	5,536,000,000	4,800,000,000	3,906,000,000	11,790,000,000	8,048,000,000	9,216,000,000	8,860,000,000	11,835,000,000	14,028,000,000	11,758,000,000	11,534,000,000	11,789,000,000	8,520,000,000	11,034,000,000	22,195,000,000		4,928,000,000	4,575,000,000	8,020,000,000		7,919,000,000	9,771,000,000	9,126,000,000	8,666,000,000	10,601,000,000	7,949,000,000	8,216,000,000
fixed maturities, fair value option												0								3,000,000	-3,000,000	39,000,000	532,000,000	-531,000,000
partnerships												50,000,000	67,000,000	73,000,000	86,000,000	111,000,000	284,000,000	56,000,000	83,000,000	34,000,000	86,000,000	45,000,000	48,000,000	58,000,000	55,000,000	63,000,000	104,000,000	145,000,000	-14,000,000	166,000,000	86,000,000	153,000,000	308,000,000	23,000,000	79,000,000	28,000,000	74,000,000	72,000,000	130,000,000	48,000,000	37,000,000	23,000,000	46,000,000	48,000,000
less: net increase in cash classified within assets held for sale																-2,000,000
net realized gains
amounts paid for business acquired, net of cash acquired
net realized capital losses																	-147,000,000	-80,000,000	-99,000,000	231,000,000			39,000,000	176,000,000	28,000,000	261,000,000			194,000,000	1,219,000,000			816,000,000	3,449,000,000				363,000,000
less: net decrease in cash classified within assets held for sale																		-1,000,000
income tax received																		32,000,000	-90,000,000
gain on sale of business
net proceeds from (payments for) from short-term investments
net transfers from separate accounts related to investment and universal life-type contracts																					2,182,000,000	2,012,000,000	3,231,000,000	2,418,000,000	2,411,000,000	1,878,000,000	3,996,000,000	124,000,000	1,785,000,000	1,772,000,000	1,510,000,000	2,136,000,000
repayments at maturity or settlement of consumer notes																					-35,000,000	-19,000,000				-68,000,000	-382,000,000	-302,000,000
preferred stock issued, net of issuance costs
amount paid for business acquired, net of cash acquired
acl on mortgage loans
mortgage loans, net of acl																				4,215,000,000
premiums receivable and agents’ balances																				4,529,000,000
acl on premiums receivable and agents' balances																				-145,000,000
premiums receivable and agents' balances, net of acl																				4,384,000,000
reinsurance recoverables																				5,641,000,000											223,000,000	-334,000,000	319,000,000	-97,000,000	24,000,000	54,000,000	70,000,000	-8,000,000	388,000,000	37,000,000	-249,000,000	228,000,000	723,000,000	369,000,000	-335,000,000	284,000,000	-19,000,000	-137,000,000
acl and allowance for disputed amounts on reinsurance recoverables																				-114,000,000
reinsurance recoverables, net of allowance for uncollectible reinsurance																				5,527,000,000
deferred income tax asset																				299,000,000
other liabilities																				-5,157,000,000
retained earnings																				12,685,000,000
federal home loan bank of boston ("fhlbb") advances
net increase in securities loaned or sold under agreements to repurchase																				-237,000,000
net realized capital (gains) losses																												276,000,000				-84,000,000				1,371,000,000				-46,000,000	-22,000,000	-27,000,000	179,000,000	121,000,000
pension settlement expense
increase in accrued and deferred income taxes
impact of tax reform on accrued and deferred income taxes
increase in unpaid losses and loss adjustment expenses, reserve for future policy benefits, and unearned premiums
equity securities, available-for-sale																					109,000,000	8,000,000	98,000,000	24,000,000	118,000,000	49,000,000	50,000,000	108,000,000	351,000,000	116,000,000	171,000,000	311,000,000	-379,000,000	851,000,000	96,000,000	48,000,000	18,000,000	69,000,000	116,000,000	265,000,000	229,000,000	167,000,000	69,000,000	49,000,000
net payments for derivatives
net (payments for) proceeds from short-term investments
net (return) issuance of shares under incentive and stock compensation plans
net increase in cash, including cash classified as assets held for sale
net increase in cash																					-8,000,000	691,000,000	-419,000,000	255,000,000	355,000,000	-1,291,000,000	919,000,000	-63,000,000	-275,000,000	-141,000,000	707,000,000	40,000,000	-152,000,000	-121,000,000	-164,000,000	237,000,000	59,000,000	328,000,000	-166,000,000	366,000,000	69,000,000			121,000,000	454,000,000	-412,000,000	291,000,000	124,000,000
cash — beginning of period																					0	0	0	2,062,000,000	0	0	0	2,142,000,000	0	0	0	1,811,000,000		0	0	2,011,000,000		0	0	1,424,000,000		0	0	1,273,000,000	0	0	1,148,000,000	0
cash — end of period																					-8,000,000	691,000,000	-419,000,000	2,317,000,000	355,000,000	-1,291,000,000	919,000,000	2,079,000,000	-275,000,000	-141,000,000	707,000,000	1,851,000,000		-121,000,000	-164,000,000	2,248,000,000		328,000,000	-166,000,000	1,790,000,000		274,000,000	-313,000,000	1,394,000,000	454,000,000	-412,000,000	1,439,000,000	124,000,000
•
amortization of deferred policy acquisition costs and present value of future profits																					608,000,000	1,320,000,000	835,000,000	664,000,000	517,000,000	438,000,000	938,000,000	651,000,000	647,000,000	687,000,000	674,000,000	2,259,000,000	1,070,000,000	1,927,000,000	806,000,000	468,000,000	804,000,000	476,000,000	837,000,000	872,000,000	1,073,000,000	839,000,000	829,000,000	817,000,000	816,000,000	762,000,000	772,000,000	694,000,000
additions to deferred policy acquisition costs and present value of future profits																					-647,000,000	-655,000,000	-653,000,000	-653,000,000	-649,000,000	-661,000,000	-658,000,000	-680,000,000	-698,000,000			-734,000,000	-838,000,000	-934,000,000	-947,000,000	-956,000,000	-1,017,000,000	-1,060,000,000	-1,061,000,000	-1,056,000,000	-1,032,000,000	-998,000,000	-1,024,000,000	-1,038,000,000	-1,027,000,000	-1,003,000,000	-1,057,000,000	-984,000,000
change in reserve for future policy benefits and unpaid losses and loss adjustment expenses and unearned premiums																					142,000,000	658,000,000	690,000,000	-39,000,000	-76,000,000	-217,000,000	167,000,000	33,000,000	-345,000,000
change in reinsurance recoverables																					0	2,000,000	-92,000,000	59,000,000	106,000,000	85,000,000	117,000,000	45,000,000	84,000,000
change in receivables and other assets																					241,000,000	-113,000,000	-290,000,000	-49,000,000	466,000,000	-101,000,000	252,000,000	-180,000,000	168,000,000
change in payables and accruals																					-350,000,000	-228,000,000	110,000,000	-23,000,000	-520,000,000	250,000,000	-233,000,000	-109,000,000	-671,000,000
change in accrued and deferred income taxes																					369,000,000	-56,000,000	-483,000,000	67,000,000	566,000,000	123,000,000	-256,000,000	128,000,000	6,000,000
net receipts (disbursements) from investment contracts related to policyholder funds — international variable annuities
net increase in equity securities, trading																					271,000,000				-325,000,000				1,193,000,000
goodwill impairment																									0	0			0	0	0	32,000,000
proceeds from business sold																					0	0	0	278,000,000	111,000,000	0					-1,000,000	8,000,000
derivatives																					-883,000,000	1,903,000,000	165,000,000	-465,000,000	-842,000,000	-80,000,000	836,000,000	-252,000,000			-581,000,000	610,000,000
change in policy loans																					175,000,000	12,000,000			-1,000,000	2,000,000	-5,000,000	-3,000,000	35,000,000	-5,000,000	-7,000,000	11,000,000	-49,000,000	-13,000,000	-28,000,000	-57,000,000	-11,000,000			-48,000,000	6,000,000	52,000,000	-103,000,000	9,000,000
change in payables for collateral under securities lending																									0	0	-23,000,000	-23,000,000	-154,000,000	-509,000,000	-812,000,000	-1,450,000,000	-1,066,000,000	-140,000,000	-292,000,000	93,000,000	172,000,000	317,000,000	530,000,000	1,199,000,000	550,000,000	12,000,000	72,000,000	336,000,000
proceeds from issuance of long-term debt																									0	0	0	1,090,000,000
repayments at maturity for long-term debt and payments on capital lease obligations																									0	0			0
change in commercial paper
net proceeds from issuance of mandatory convertible preferred stock																									0	0	0	556,000,000
net proceeds from issuance of common shares under public offering																									0
redemption of preferred stock issued to the u.s. treasury																									0	0	0	-3,400,000,000
proceeds from issuance of preferred stock and warrants to u.s. treasury																													0	0
net proceeds from issuance of common shares under discretionary equity issuance plan
proceeds from net issuance of shares under incentive and stock compensation plans and excess tax benefit																								-2,000,000	8,000,000	3,000,000	6,000,000	8,000,000	-1,000,000
changes in bank deposits and payments on bank advances																					-227,000,000	-20,000,000	-9,000,000	-1,000,000	-38,000,000	-13,000,000	-13,000,000	-30,000,000	-102,000,000
income taxes paid																					-66,000,000	-1,000,000	220,000,000	26,000,000	59,000,000
accounting policy
fair value measurements
investments and derivative instruments
reinsurance
deferred policy acquisition costs and present value of future profits
goodwill and other intangible assets
separate accounts, death benefits and other insurance benefit features
sales inducements
reserve for future policy benefits and unpaid losses and loss adjustment expenses
commitments and contingencies
income taxes																											161,000,000	87,000,000	149,000,000	76,000,000	130,000,000	-598,000,000	21,000,000	167,000,000			85,000,000	89,000,000	287,000,000	-10,000,000	154,000,000	-3,000,000	211,000,000	-183,000,000	147,000,000	130,000,000	81,000,000	-12,000,000
employee benefit plans
net receipts (disbursements) from investment contracts related to policyholder funds - international variable annuities
proceeds from net issuance of shares under incentive and stock compensation plans, excess tax benefit and other																						4,000,000
tax benefit at u.s. federal statutory rate																						22,000,000				325,000,000
tax-exempt interest																						1,000,000	-1,000,000	-37,000,000		0
dividends-received deduction																						48,000,000
valuation allowance																						95,000,000	-87,000,000	-2,000,000
other																						2,000,000	15,000,000	-9,000,000		8,000,000					233,000,000	-126,000,000	1,067,000,000	-661,000,000	-151,000,000	-16,000,000	-56,000,000	-42,000,000	-18,000,000	-316,000,000	108,000,000	-223,000,000	190,000,000	128,000,000	220,000,000	45,000,000	146,000,000	-149,000,000
income tax expense																						168,000,000	-328,000,000	59,000,000		339,000,000
net disbursements from investment contracts related to policyholder funds — international variable annuities																							-60,000,000	-496,000,000			-1,880,000,000	-257,000,000
net decrease in equity securities, trading																							61,000,000	481,000,000			1,870,000,000	268,000,000
payments on capital lease obligations																												-68,000,000			0	-24,000,000	0	0	-11,000,000	-26,000,000
tax expense at u.s. federal statutory rate																								144,000,000
dividends received deduction																								-37,000,000		6,000,000
net issuance (repayment) at maturity or settlement of consumer notes
net proceeds from issuance of convertible preferred stock and warrants
fair value
separate accounts
contingencies
pension plans and postretirement healthcare and life insurance benefit plans
net receipts from investment contracts related to policyholder funds — international variable annuities
investment valuation allowance
nondeductible costs associated with warrants
net proceeds from issuance of shares under public offering																											0	1,600,000,000
net proceeds from issuance of shares under discretionary equity issuance plan																													0	873,000,000
net cash paid (received) during the period for:
interest																											172,000,000	61,000,000	172,000,000	60,000,000	173,000,000	70,000,000	100,000,000	58,000,000	83,000,000	45,000,000	85,000,000	52,000,000	84,000,000	36,000,000	70,000,000	68,000,000	79,000,000	57,000,000	55,000,000	73,000,000	52,000,000	40,000,000
income
less: preferred stock dividends and accretion of discount																												483,000,000
net income available to common shareholders																												-164,000,000		-264,000,000								224,000,000	-249,000,000	876,000,000		282,000,000	-252,000,000	728,000,000			666,000,000
common shares
basic																												-420,000
weighted-average common shares outstanding																												393,700,000
diluted																												-420,000
weighted-average shares outstanding and dilutive potential common shares																												393,700,000
earnings per common share
net issuance (repayments) at maturity or settlement of consumer notes																													-57,000,000
proceeds from issuance of convertible preferred shares
proceeds from issuance of warrants
fair value measurements – financial instruments excluding guaranteed living benefits
fair value measurements – guaranteed living benefits
income tax
derivative payments
purchase price of businesses acquired																														0	-7,000,000	-8,000,000		0	0	-94,000,000
change in short-term debt																														0	-354,000,000	-21,000,000					0	275,000,000	-69,000,000	-131,000,000
additions to deferred policy acquisition costs and present value of future profits change in:
reserve for future policy benefits and unpaid losses and loss adjustment expenses and unearned premiums																															-367,000,000	1,700,000,000		1,113,000,000	387,000,000	189,000,000		539,000,000	427,000,000	250,000,000
receivables and other assets																															270,000,000	-21,000,000		247,000,000	459,000,000	-60,000,000		174,000,000
payables and accruals																															7,000,000	-396,000,000	570,000,000	17,000,000	-165,000,000	-525,000,000	-131,000,000	-28,000,000	345,000,000	120,000,000	395,000,000	-212,000,000	-18,000,000	-452,000,000	137,000,000	-185,000,000	-197,000,000	228,000,000
accrued and deferred income taxes																															-67,000,000	-276,000,000	-552,000,000	-1,536,000,000	86,000,000	-154,000,000	81,000,000	253,000,000	-62,000,000	347,000,000	85,000,000	361,000,000	-214,000,000	425,000,000	-65,000,000	164,000,000	139,000,000	22,000,000
net receipts to investment contracts related to policyholder funds -international variable annuities
change in all other securities																															-37,000,000	144,000,000	-31,000,000	251,000,000	-456,000,000	-319,000,000	-244,000,000	-24,000,000	-233,000,000	-122,000,000	-38,000,000	65,000,000	-340,000,000	-141,000,000
additions to property and equipment																															-9,000,000	-49,000,000	-87,000,000	-10,000,000	-118,000,000	-67,000,000	-24,000,000	-161,000,000	-29,000,000	-61,000,000	-79,000,000	-51,000,000	-44,000,000	-21,000,000	-53,000,000	-101,000,000	-15,000,000
proceeds from issuance of consumer notes																																	0	141,000,000	142,000,000	162,000,000	86,000,000	135,000,000	153,000,000	177,000,000	217,000,000
proceeds from issuance of shares under incentive and stock compensation plans																															0	7,000,000		13,000,000	15,000,000	19,000,000		22,000,000				25,000,000	53,000,000	22,000,000	71,000,000	108,000,000	105,000,000	40,000,000
excess tax benefit on stock-based compensation
return of shares under incentive and stock compensation plans to treasury stock																															0	-3,000,000	-1,000,000	0	0	-17,000,000	-1,000,000	-1,000,000	0	-12,000,000
basic loss per common share
less: preferred stock dividends
diluted loss per common share [1]
warrants
stock compensation plans
net income available to common shareholders plus assumed conversions																																						224,000,000	-249,000,000	876,000,000		282,000,000	-252,000,000	728,000,000			666,000,000
change in:
net receipts to investment contracts related to policyholder funds — international variable annuities																																-387,000,000
net decrease in equity securities, held for trading																																449,000,000
issuance of long-term debt																																	1,183,000,000	0	991,000,000	496,000,000	0	0	0	495,000,000								0
repayments at maturity of consumer notes																																-8,000,000
excess tax expense on stock-based compensation																																-11,000,000
reserve for future policy benefits, unpaid losses and loss adjustment expenses and unearned premiums
receivables																																								-82,000,000	-72,000,000	73,000,000	14,000,000	-49,000,000	30,000,000	3,000,000	-53,000,000	-149,000,000
net increase in equity securities, held for trading																																	4,094,000,000	-3,034,000,000	-1,801,000,000	3,036,000,000	-413,000,000	-756,000,000	-2,400,000,000	-1,132,000,000	-1,734,000,000	-1,803,000,000	-44,000,000	-2,028,000,000	-3,770,000,000	-3,307,000,000	-2,220,000,000	-1,701,000,000
net receipts (disbursements) from investment contracts credited to policyholder funds —
international variable annuities associated with equity securities, held for trading
fixed maturities, available-for-sale, including short-term investments
derivative receipts
purchase price adjustment of business acquired																																																3,000,000
sale of subsidiary, net of cash transferred
net transfers from (to) separate accounts related to investment and universal life-type contracts																																	1,769,000,000	1,859,000,000	2,048,000,000	1,677,000,000		-1,543,000,000	84,000,000	-767,000,000
issuance of shares from equity unit contracts																																									330,000,000
repayment/maturity of long-term debt																																					0				-700,000,000	-200,000,000			0			0
issuance of convertible preferred shares
issuance of warrants
repayments of consumer notes
proceeds from issuances of shares under incentive and stock compensation plans																																								74,000,000
excess tax benefits on stock-based compensation																																	1,000,000	2,000,000			16,000,000	15,000,000			-21,000,000	4,000,000	13,000,000	14,000,000
dividends paid																																	-159,000,000	-165,000,000	-167,000,000	-169,000,000	-155,000,000	-158,000,000	-161,000,000	-162,000,000	-125,000,000	-123,000,000	-121,000,000	-91,000,000	-86,000,000	-86,000,000	-86,000,000	-83,000,000
cash — beginning of year
cash — end of year
supplemental disclosure of cash flow information — net cash paid during the year for:
net receipts (to) from investment contracts related to policyholder funds - international variable annuities
repayments at maturity of long-term debt
net cash paid during the period for:
net receipts (to) from investment contracts related to policyholder funds — international variable annuities
net receipts (to) from investment contracts credited to policyholder accounts associated with equity securities, held for trading																																				-3,175,000,000
net receipts from investment contracts credited to policyholder accounts associated with equity securities, held for trading																																					249,000,000	656,000,000	2,467,000,000	1,323,000,000	1,723,000,000	1,905,000,000			3,909,000,000			1,834,000,000
transfers from (to) separate accounts related to investment and universal life-type contracts
supplemental disclosure of cash flow information:
net cash paid during the year for:
basic earnings per share
diluted earnings per share
march 31, 2007
march 31, 2006
equity units
cumulative effect of accounting change, net of tax																																																0
issuance of common stock in underwritten offering																																																0
return of shares under incentive and stock compensation plans																																									-1,000,000	0	0	-4,000,000
cash – beginning of year
cash – end of year
reserve for future policy benefits and unpaid claims and claim adjustment expenses and unearned premiums																																										292,000,000	-90,000,000	198,000,000	875,000,000	-3,000,000	221,000,000	874,000,000
issuance of short-term debt, net of repayments
net receipts from investment and universal life-type contracts																																										543,000,000	688,000,000	43,000,000
issuance of short-term debt
net decrease in cash
net receipts from investment and universal life-type contracts credited to policyholders accounts associated with equity securities, held for trading																																												2,105,000,000			2,367,000,000
march 31, 2005
net realized capital gains																																													33,000,000	17,000,000	-128,000,000	-44,000,000
purchase of available-for-sale investments																																													-8,423,000,000	-9,196,000,000	-10,587,000,000	-7,299,000,000
sale of available-for-sale investments																																													5,580,000,000	7,434,000,000	8,905,000,000	4,333,000,000
maturity of available-for-sale investments																																													1,128,000,000	911,000,000	750,000,000	1,379,000,000
repayment of short-term debt																																																0
net receipts (disbursements) from investment and universal life-type contracts credited to policyholder accounts																																													717,000,000
return of shares under incentive stock compensation plans																																													-1,000,000
repayment of long-term debt
net receipts from investment and universal life-type contracts charged against policyholder accounts																																															548,000,000
march 31, 2004
additions to property, plant and equipment																																																-49,000,000
net receipts from investment and universal life-type contracts credited to policyholder accounts
net income, as reported																																																61,000,000
add: stock-based employee compensation expense included in reported net income, net of related tax effects [1]																																																-2,000,000
deduct: total stock-based employee compensation expense determined under the fair value method for all awards, net of related tax effects																																																2,000,000
pro forma net income [2]																																																61,000,000
earnings per share:
basic – as reported																																																200,000
basic – pro forma [2]																																																200,000
diluted – as reported [3]																																																200,000
diluted – pro forma [2] [3]																																																200,000
net receipts from investment and universal life-type contracts credited to policyholder accounts associated with equity securities, held for trading
issuance (repayment) of short-term debt
cash - beginning of period
cash - end of period

We provide you with 20 years of cash flow statements for The Hartford Financial Services Group stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of The Hartford Financial Services Group stock. Explore the full financial landscape of The Hartford Financial Services Group stock with our expertly curated income statements.

The information provided in this report about The Hartford Financial Services Group stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.